Package 59651-167-30

{"route": ["ORAL"], "spl_id": "a805c27a-1154-4aac-9af8-bbd755be027f", "openfda": {"nui": ["N0000175462", "M0015066", "N0000009947"], "unii": ["OTT9J7900I", "G70B4ETF4S"], "rxcui": ["1744001", "1744005", "1744009"], "spl_set_id": ["974d2ec8-1b51-4e69-991d-0d5dea8360f4"], "pharm_class_cs": ["Nucleosides [CS]"], "pharm_class_epc": ["Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (59651-167-30)", "package_ndc": "59651-167-30", "marketing_start_date": "20230309"}], "brand_name": "Emtricitabine and Tenofovir Disoproxil Fumarate", "product_id": "59651-167_a805c27a-1154-4aac-9af8-bbd755be027f", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleosides [CS]", "Nucleosides [CS]"], "product_ndc": "59651-167", "generic_name": "Emtricitabine and Tenofovir Disoproxil Fumarate", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Emtricitabine and Tenofovir Disoproxil Fumarate", "active_ingredients": [{"name": "EMTRICITABINE", "strength": "167 mg/1"}, {"name": "TENOFOVIR DISOPROXIL FUMARATE", "strength": "250 mg/1"}], "application_number": "ANDA211640", "marketing_category": "ANDA", "marketing_start_date": "20230309", "listing_expiration_date": "20261231"}